On August 1, GLONGHUI | Changjiang Life Technology (0775.HK) announced that in the first half of 2023, the company's unaudited shareholders should account for about HK$37 million in net profit, down 43% from the same period last year.
长江生命科技：上半年股东应占净利润同比降43%
Changjiang Life Science: Net profit attributable to shareholders fell 43% year-on-year in the first half of the year
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.